Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, TDS, FVT

Nektar to Webcast Presentation at the Cowen and Company 38th Annual Health Care Conference in Boston


SAN FRANCISCO, March 7, 2018 /PRNewswire/ -- Nektar Therapeutics' (Nasdaq: NKTR) Senior Vice President and Chief Scientific Officer, Jonathan Zalevsky, Ph.D., is scheduled to present at the upcoming Cowen and Company 38th Annual Health Care Conference in Boston on Wednesday, March 14, 2018 at 8:00 a.m. Eastern Time. 

The presentation will be accessible via a Webcast through a link posted on the Investors, Events Calendar section of the Nektar website: http://ir.nektar.com/events-and-presentations/events. This Webcast will be available for replay until April 30, 2018.

About Nektar

Nektar Therapeutics is a research-based, development stage biopharmaceutical company whose mission is to discover and develop innovative medicines to address the unmet medical needs of patients. Our R&D pipeline of new investigational medicines includes treatments for cancer, autoimmune disease and chronic pain. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new therapeutic candidates. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.

Contact:

Investors
Jennifer Ruddock of Nektar Therapeutics
415-482-5585

 

SOURCE Nektar Therapeutics


These press releases may also interest you

at 02:05
PureTech Health: Notice of Results
PureTech Health plc ("PureTech" or the "Company") plans to publish its Annual Report and Accounts and financial results for the year ended December 31, 2023, on Thursday, April 25, 2024. A presentation and conference call to discuss the results...

at 02:05
Hansa Biopharma interim report January-March 2024
Hansa Biopharma, the pioneer in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced its business update and year-end report for January to March 2024. Highlights for the first quarter of 2024      Strong commercial...

at 02:00
Nissan Formula E, 2nd Place on the Podium at Tokyo Home Race.
Nissan Motor Co. Ltd. provided the Nissan Formula E Team, which participated in the Formula E Tokyo E-Prix on 30 March 2024 (the first ever held in Japan), with energy generated by "VOICE CHARGE", a disruptive new project bringing a new form of 'fan...

at 01:51
Flash News: OKX Wallet Web Extension Expands to Include Luminex Access
OKX, a leading Web3 technology company, has issued updates for April 18, 2024. OKX Wallet Web Extension Expands to Include Luminex...

at 01:45
EQT AB (publ) Q1 Announcement 2024
A promising start to 2024 - and to EQT's fourth decade "EQT started the year with the successful completion of two fundraises, EQT X and EQT Future, with total commitments of more than EUR 25 billion. Investment activity continued at a good pace and,...

at 01:31
Bamboo Works Spotlights Potential for Smartphone Recycling in Expert Opinion from ATRenew Chairman Kerry Chen
Kerry Xuefeng Chen, Chairman and CEO of ATRenew (RERE.US), a leading technology-driven pre-owned consumer electronic transactions and services platform in China, discusses the huge potential for recycling of smartphones, electronics and even luxury...

More news about Science and technology...


News published on and distributed by: